Platelet-activating factor (PAF) receptor as a promising target for cancer cell repopulation after radiotherapy

A major drawback of radiotherapy is the accelerated growth of the surviving tumor cells. Radiotherapy generates a variety of lipids that bind to the receptor for platelet-activating factor, expressed by cells in the tumor microenvironment. In the present study, using the TC-1 tumor cell line, we fou...

Descripción completa

Detalles Bibliográficos
Autores principales: da Silva-Jr, I A, Chammas, R, Lepique, A P, Jancar, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5294253/
https://www.ncbi.nlm.nih.gov/pubmed/28134937
http://dx.doi.org/10.1038/oncsis.2016.90

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5294253/
https://www.ncbi.nlm.nih.gov/pubmed/28134937
http://dx.doi.org/10.1038/oncsis.2016.90

Ejemplares similares